Attached files
| file | filename |
|---|---|
| EX-5.1 - OPINION OF AKERMAN LLP. - NRX Pharmaceuticals, Inc. | brpa_ex51.htm |
| S-1MEF - S-1MEF - NRX Pharmaceuticals, Inc. | brpa_s1mef.htm |
Exhibit
23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S
CONSENT
We
consent to the incorporation by reference in this
Registration Statement of Big Rock Partners Acquisition Corp. (the
“Company”) on Form S-1 of our report dated October 13,
2017, which includes an explanatory paragraph as to the
Company’s ability to continue as a going concern, with
respect to our audit of the financial statements of Big Rock
Partners Acquisition Corp. as of September 30, 2017 and for the
period from September 18, 2017 (inception) through September 30,
2017, appearing in the Registration Statement on Form S-1, as
amended (File No. 333-220947) of Big Rock Partners
Acquisition Corp.
/s/
Marcum llp
Marcum
llp
New
York, NY
November
20, 2017